COVID-19: FAQs in Pediatric Cardiac Surgery—A Sequel

COVID-19 is not going away anytime soon and it continues to pose unprecedented challenges to the world and to the health care industry, particularly the cardiac surgical specialties where exposure is potentially greater because of disease complexity, longer ICU durations, and overall hospital length of stay. This ongoing ordeal has precipitated unmatched collaborations among congenital heart surgeons across regions, nations, and continents, as well as unifying partnerships with other specialties devoted to the care of these complex patients. This partnership among cardiac surgeons, intensivists, and infectious disease colleagues is an example of the synergy we can develop to continue to improve care for our complex patients in this new era. Unprecedented times in this crucible of trial necessitate standardization, constant reevaluation of new information, and instant readiness and adaptability in order to safely improve the care of our patients. That’s what we are doing. As the pandemic and virus evolve, we will persist in the examination of COVID-19-related information and how it impacts our patients, so we provide the best care during these ever-changing times.